FDA Clears Tumor Profiling Assay that Analyzes 425 Cancer-Related Genes
The NGS-based test joins CE-IVD and NMPA approvals for global market access.
The NGS-based test joins CE-IVD and NMPA approvals for global market access.
Breath tests are increasingly being explored and implemented in clinical diagnosis, offering a non-invasive means to detect a variety of conditions like blood cancer, lung disease, lower respiratory tract infections, and gastroparesis.
Researchers have developed an AI blood test called Fragle to accurately and affordably track cancer treatment response and detect relapse.
Despite limited progress in prognosis, recent advancements in molecular diagnostics is transforming diagnosis of cancer of unknown primary.
Read MoreArtificial intelligence (AI) with mathematical modeling, while useful, isn’t the only method that should be used in cancer prediction.
Read MoreMULGONET, a novel multi-omics framework, improves tumor recurrence prediction by integrating gene ontology-guided architecture.
Read MoreA study highlights the role of exRNA in head and neck cancers (HNCs), emphasizing their potential as non-invasive biomarkers for diagnosis.
Read MoreThe ORACLE test can predict lung cancer survival at diagnosis accurately, offering new hope for tailored treatments in stage 1 patients.
Read MoreLeica Biosystems and Indica Labs will develop a next-gen digital pathology platform and accelerate AI-enabled CDx for cancer care.
Read MoreA new study introduced an AI-powered diagnostic model with 94.49% accuracy to improve skin cancer detection and patient outcomes.
Read MoreGenomenon, Inc. has announced the development of the G3 knowledgebase, an advanced genomic AI platform that consolidates genomic data.
Read MoreFunction Health will offer GRAIL’s Galleri multi-cancer early detection test, empowering proactive cancer care through a simple blood draw.
Read MoreResearchers identified 27 protein biomarkers in blood serum that can predict cardiomyopathy risk in pediatric cancer survivors.
Read MoreThe Center for Innovation and Translation of POC Technologies for Equitable Cancer Care showcased POC innovations for cancer detection.
Read MoreSakura Finetek Europe and MEDIPATH partnered to enhance cancer diagnostics by deploying automated embedding systems in key pathology centers.
Read MoreResearchers have developed a novel testing strategy for mesothelioma cancer, focusing on detecting chromosomal rearrangements in cancer DNA.
Read MoreResearchers developed a non-invasive cancer detection tool using nanowire-based miRNA extraction and AI to identify lung cancer in urine.
Read MoreA study found that the teledermoscopy system achieved 91% diagnostic accuracy for skin cancer, closely matching in-person evaluations.
Read More